BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 32729113)

  • 21. Acquisition of a CD19-negative myeloid phenotype allows immune escape of MLL-rearranged B-ALL from CD19 CAR-T-cell therapy.
    Gardner R; Wu D; Cherian S; Fang M; Hanafi LA; Finney O; Smithers H; Jensen MC; Riddell SR; Maloney DG; Turtle CJ
    Blood; 2016 May; 127(20):2406-10. PubMed ID: 26907630
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Spontaneous reversion of a lineage switch following an initial blinatumomab-induced ALL-to-AML switch in
    Wölfl M; Rasche M; Eyrich M; Schmid R; Reinhardt D; Schlegel PG
    Blood Adv; 2018 Jun; 2(12):1382-1385. PubMed ID: 29898879
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A case of
    Forlenza CJ; Zhang Y; Yao J; Benayed R; Steinherz P; Ramaswamy K; Kessel R; Roshal M; Shukla N
    Cold Spring Harb Mol Case Stud; 2018 Dec; 4(6):. PubMed ID: 30455225
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Primary Cutaneous Diffuse Large B-Cell Lymphoma With KMT2A-MLLT3: An Infantile Case Study.
    Hiroki H; Yoshimi A; Kato K; Yanai T; Koike K
    J Pediatr Hematol Oncol; 2019 Nov; 41(8):657-658. PubMed ID: 31205223
    [No Abstract]   [Full Text] [Related]  

  • 25. Acute leukemias harboring KMT2A/MLLT10 fusion: a 10-year experience from a single genomics laboratory.
    Peterson JF; Sukov WR; Pitel BA; Smoley SA; Pearce KE; Meyer RG; Williamson CM; Smadbeck JB; Vasmatzis G; Hoppman NL; Greipp PT; Baughn LB; Ketterling RP
    Genes Chromosomes Cancer; 2019 Aug; 58(8):567-577. PubMed ID: 30707474
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hematopoietic transformation in the absence of MLL1/KMT2A: distinctions in target gene reactivation.
    Chen Y; Ernst P
    Cell Cycle; 2019 Jul; 18(14):1525-1531. PubMed ID: 31161857
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Azacitidine successfully maintained the second remission in an infant with KMT2A-rearranged acute lymphoblastic leukemia who relapsed after unrelated cord blood transplantation.
    Chijimatsu I; Imanaka Y; Tomizawa D; Eguchi M; Nishimura S; Karakawa S; Miki M; Hamamoto K; Fujita N
    Pediatr Blood Cancer; 2017 Dec; 64(12):. PubMed ID: 28675638
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Revisiting the biology of infant t(4;11)/MLL-AF4+ B-cell acute lymphoblastic leukemia.
    Sanjuan-Pla A; Bueno C; Prieto C; Acha P; Stam RW; Marschalek R; Menéndez P
    Blood; 2015 Dec; 126(25):2676-85. PubMed ID: 26463423
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Molecular characterization of KMT2A fusion partner genes in 13 cases of pediatric leukemia with complex or cryptic karyotypes.
    Ney Garcia DR; de Souza MT; de Figueiredo AF; Othman MAK; Rittscher K; Abdelhay E; Capela de Matos RR; Meyer C; Marschalek R; Land MGP; Liehr T; Ribeiro RC; Silva MLM
    Hematol Oncol; 2017 Dec; 35(4):760-768. PubMed ID: 27282883
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Unique Familial MLL(KMT2A)-Rearranged Precursor B-Cell Infant Acute Lymphoblastic Leukemia in Non-twin Siblings.
    Urtishak KA; Robinson BW; Rappaport EF; Sarezky MD; Biegel JA; Nichols KE; Wilmoth DM; Wang LS; Stern JW; Felix CA
    Pediatr Blood Cancer; 2016 Jul; 63(7):1175-80. PubMed ID: 26999444
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Osteopontin-c is overexpressed in KMT2A-AFF1 positive pediatric B-cell lymphoblastic leukemia when compared to those with ETV6-RUNX1".
    da Fonseca Bastos ACS; da Silva Rezende AC; Ferreira LB; Blunck CB; Pombo-de-Oliveira MS; Emerenciano M; Gimba ERP
    Leuk Res; 2020 Apr; 91():106316. PubMed ID: 32114371
    [No Abstract]   [Full Text] [Related]  

  • 32. Long-term remission of therapy-related acute myeloid leukemia with a new t(11;18)(q23;q21.2) translocation and KMT2A-ME2 (MLL-ME2) fusion gene.
    Szotkowski T; Jarošová M; Zimmermannová O; Meyer C; Marschalek R; Zuna J; Hubáček J; Indrák K
    Cancer Genet; 2015 Dec; 208(12):610-4. PubMed ID: 26556690
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Acute myeloid leukemia with t(10;11)(p11-12;q23.3): Results of Russian Pediatric AML registration study.
    Zerkalenkova E; Lebedeva S; Kazakova A; Tsaur G; Starichkova Y; Timofeeva N; Soldatkina O; Aprelova E; Popov A; Ponomareva N; Baidun L; Meyer C; Novichkova G; Maschan M; Maschan A; Marschalek R; Olshanskaya Y
    Int J Lab Hematol; 2019 Apr; 41(2):287-292. PubMed ID: 30624859
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A pediatric case of
    Murphy L; Siegele B; Carstens B; Hartman L; Faulk K
    Leuk Lymphoma; 2024 Jun; 65(6):843-847. PubMed ID: 38372299
    [No Abstract]   [Full Text] [Related]  

  • 35. A pediatric case of secondary T-cell acute lymphoblastic leukemia with KMT2A-MAML2 developing after hepatoblastoma treatment.
    Takahashi Y; Terui K; Chinen Y; Tandai S; Kudo K; Sasaki S; Tono C; Taki T; Ito E
    Pediatr Blood Cancer; 2020 Jan; 67(1):e28033. PubMed ID: 31599492
    [No Abstract]   [Full Text] [Related]  

  • 36. Extramedullary relapse of
    Aldoss I; Song JY
    Blood; 2018 May; 131(22):2507. PubMed ID: 29853461
    [No Abstract]   [Full Text] [Related]  

  • 37. Integrative epigenomic analysis identifies biomarkers and therapeutic targets in adult B-acute lymphoblastic leukemia.
    Geng H; Brennan S; Milne TA; Chen WY; Li Y; Hurtz C; Kweon SM; Zickl L; Shojaee S; Neuberg D; Huang C; Biswas D; Xin Y; Racevskis J; Ketterling RP; Luger SM; Lazarus H; Tallman MS; Rowe JM; Litzow MR; Guzman ML; Allis CD; Roeder RG; Müschen M; Paietta E; Elemento O; Melnick AM
    Cancer Discov; 2012 Nov; 2(11):1004-23. PubMed ID: 23107779
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A case of pediatric acute myeloid leukemia with t(11;16)(q23;q24) leading to a novel KMT2A-USP10 fusion gene.
    Zerkalenkova E; Lebedeva S; Kazakova A; Baryshev P; Meyer C; Marschalek R; Novichkova G; Maschan M; Maschan A; Olshanskaya Y
    Genes Chromosomes Cancer; 2018 Oct; 57(10):522-524. PubMed ID: 30107050
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Subclonality and prenatal origin of RAS mutations in KMT2A (MLL)-rearranged infant acute lymphoblastic leukaemia.
    Emerenciano M; Barbosa Tda C; de Almeida Lopes B; Meyer C; Marschalek R; Pombo-de-Oliveira MS
    Br J Haematol; 2015 Jul; 170(2):268-71. PubMed ID: 25613690
    [No Abstract]   [Full Text] [Related]  

  • 40. MLL-rearranged mixed phenotype acute leukemia masquerading as B-cell ALL.
    Yang W; Tran P; Khan Z; Rezk S; O'Brien S
    Leuk Lymphoma; 2017 Jun; 58(6):1498-1501. PubMed ID: 27774846
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.